CareView Communications, Inc. (CRVW)
USD 0.02
(-1.96%)
USD 0.02
(-1.96%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 139.09 Thousand USD | -99.04% |
| 2022 | 14.52 Million USD | -48.93% |
| 2021 | 28.44 Million USD | -17.71% |
| 2020 | 34.56 Million USD | -51.61% |
| 2019 | 71.43 Million USD | 2.97% |
| 2018 | 69.37 Million USD | 7.43% |
| 2017 | 64.57 Million USD | 3.7% |
| 2016 | 62.27 Million USD | 15.9% |
| 2015 | 53.72 Million USD | 130.83% |
| 2014 | 23.27 Million USD | 29.73% |
| 2013 | 17.94 Million USD | 44.24% |
| 2012 | 12.43 Million USD | 201.27% |
| 2011 | 4.12 Million USD | 1326.47% |
| 2010 | 289.44 Thousand USD | 61.14% |
| 2009 | 179.62 Thousand USD | -58.23% |
| 2008 | 430 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 46.31 Thousand USD | 0.0% |
| 2024 Q1 | 93.42 Thousand USD | 0.0% |
| 2023 Q4 | 139.09 Thousand USD | -24.11% |
| 2023 Q3 | 183.29 Thousand USD | -18.9% |
| 2023 FY | 139.09 Thousand USD | -99.04% |
| 2023 Q2 | 226.02 Thousand USD | -15.15% |
| 2023 Q1 | 266.38 Thousand USD | -98.17% |
| 2022 Q2 | 30.46 Million USD | -64.44% |
| 2022 Q1 | 85.68 Million USD | 201.22% |
| 2022 FY | 14.52 Million USD | -48.93% |
| 2022 Q4 | 14.52 Million USD | -49.97% |
| 2022 Q3 | 29.03 Million USD | -4.69% |
| 2021 Q2 | 26.51 Million USD | -67.4% |
| 2021 FY | 28.44 Million USD | -17.71% |
| 2021 Q1 | 81.32 Million USD | 135.27% |
| 2021 Q4 | 28.44 Million USD | 3.55% |
| 2021 Q3 | 27.47 Million USD | 3.63% |
| 2020 Q4 | 34.56 Million USD | 2.18% |
| 2020 Q1 | 73.88 Million USD | 3.43% |
| 2020 Q2 | 32.49 Million USD | -56.02% |
| 2020 FY | 34.56 Million USD | -51.61% |
| 2020 Q3 | 33.82 Million USD | 4.1% |
| 2019 Q4 | 71.43 Million USD | 2.29% |
| 2019 FY | 71.43 Million USD | 2.97% |
| 2019 Q1 | 69.44 Million USD | 0.1% |
| 2019 Q2 | 69.44 Million USD | -0.01% |
| 2019 Q3 | 69.83 Million USD | 0.57% |
| 2018 Q2 | 68.66 Million USD | 1.59% |
| 2018 Q1 | 67.59 Million USD | 4.67% |
| 2018 FY | 69.37 Million USD | 7.43% |
| 2018 Q4 | 69.37 Million USD | -0.25% |
| 2018 Q3 | 69.54 Million USD | 1.28% |
| 2017 Q4 | 64.57 Million USD | -7.97% |
| 2017 Q2 | 67.67 Million USD | 3.67% |
| 2017 Q1 | 65.27 Million USD | 4.83% |
| 2017 FY | 64.57 Million USD | 3.7% |
| 2017 Q3 | 70.16 Million USD | 3.69% |
| 2016 Q2 | 57.45 Million USD | 3.34% |
| 2016 FY | 62.27 Million USD | 15.9% |
| 2016 Q4 | 62.27 Million USD | 4.88% |
| 2016 Q3 | 59.37 Million USD | 3.35% |
| 2016 Q1 | 55.59 Million USD | 3.47% |
| 2015 Q1 | 29.68 Million USD | 27.52% |
| 2015 Q2 | 30.91 Million USD | 4.16% |
| 2015 Q4 | 53.72 Million USD | 64.48% |
| 2015 FY | 53.72 Million USD | 130.83% |
| 2015 Q3 | 32.66 Million USD | 5.66% |
| 2014 Q2 | 24.35 Million USD | 5.06% |
| 2014 FY | 23.27 Million USD | 29.73% |
| 2014 Q4 | 23.27 Million USD | -10.38% |
| 2014 Q3 | 25.97 Million USD | 6.63% |
| 2014 Q1 | 23.18 Million USD | 29.22% |
| 2013 Q2 | 15.18 Million USD | 5.68% |
| 2013 Q3 | 16.56 Million USD | 9.07% |
| 2013 FY | 17.94 Million USD | 44.24% |
| 2013 Q4 | 17.94 Million USD | 8.31% |
| 2013 Q1 | 14.37 Million USD | 15.53% |
| 2012 Q4 | 12.43 Million USD | 8.69% |
| 2012 FY | 12.43 Million USD | 201.27% |
| 2012 Q2 | 10.04 Million USD | 15.87% |
| 2012 Q1 | 8.66 Million USD | 109.93% |
| 2012 Q3 | 11.44 Million USD | 13.96% |
| 2011 Q2 | 1.37 Million USD | 381.78% |
| 2011 Q4 | 4.12 Million USD | 50.58% |
| 2011 FY | 4.12 Million USD | 1326.47% |
| 2011 Q1 | 285.84 Thousand USD | -1.25% |
| 2011 Q3 | 2.74 Million USD | 99.1% |
| 2010 Q3 | 105.54 Thousand USD | 0.0% |
| 2010 Q4 | 289.44 Thousand USD | 174.24% |
| 2010 FY | 289.44 Thousand USD | 61.14% |
| 2009 Q4 | 179.62 Thousand USD | 0.0% |
| 2009 FY | 179.62 Thousand USD | -58.23% |
| 2008 FY | 430 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Achiko AG | 2.12 Million USD | 93.444% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 2.65 Million USD | 94.767% |
| Cannabis Sativa, Inc. | - USD | -Infinity% |
| CompuMed, Inc. | - USD | -Infinity% |
| CompuGroup Medical SE & Co. KGaA | 777.31 Million USD | 99.982% |
| Cogstate Limited | 454.9 Thousand USD | 69.422% |
| Craneware plc | 27.37 Million USD | 99.492% |
| Caduceus Software Systems Corp. | 2.41 Million USD | 94.229% |
| Certive Solutions Inc. | 1.16 Million USD | 88.088% |
| Drug Free Solution, Inc. | - USD | -Infinity% |
| DATATRAK International, Inc. | - USD | -Infinity% |
| Strainsforpains, Inc. | 1.93 Million USD | 92.804% |
| Healixa Inc. | - USD | -Infinity% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | - USD | -Infinity% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | - USD | -Infinity% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | - USD | -Infinity% |
| IQ-AI Limited | - USD | -Infinity% |
| Cannabiz Mobile, Inc. | 494.05 Thousand USD | 71.845% |
| Mednow Inc. | 280.58 Thousand USD | 50.425% |
| Galileo Life Sciences, Inc. | - USD | -Infinity% |
| MediXall Group, Inc. | 189.45 Thousand USD | 26.58% |
| Mitesco, Inc. | - USD | -Infinity% |
| MobileSmith, Inc. | 282.53 Thousand USD | 50.767% |
| NantHealth, Inc. | 264.73 Million USD | 99.947% |
| Net Medical Xpress Solutions, Inc. | 650 Thousand USD | 78.6% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | - USD | -Infinity% |
| Patient Access Solutions, Inc. | 200 Thousand USD | 30.451% |
| Pharma-Bio Serv, Inc. | 194.03 Thousand USD | 28.312% |
| PPJ Healthcare Enterprises, Inc. | - USD | -Infinity% |
| Medical Cannabis Payment Solutions, Inc. | - USD | -Infinity% |
| Renalytix Plc | 4.33 Million USD | 96.788% |
| Revium Recovery Inc. | - USD | -Infinity% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | - USD | -Infinity% |
| Vaso Corporation | 6000.00 USD | -2218.317% |
| Vynleads, Inc. | - USD | -Infinity% |